Ledger.Open graph →
SEC Form D · Amendment · filed November 22, 2022

Lenz Therapeutics, Inc

Offering
$49.0M
Sold
$49.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Clare Ozawa · Del Mar, CADirectorZach Scheiner · Del Mar, CADirectorJames Mccollum · Del Mar, CADirectorEvert Schimmelpennink · Del Mar, CAExec · DirectorJeni Stallings · Edmond, OKDirectorTelperion Manager LLC · Bethesda, MDExec · DirectorDan Santoro · HOUSTON, TXDirectorKen Odom · HOUSTON, TXDirectorFred Guerard · Del Mar, CADirectorLevco Capital Partners LLC · New Fairfield, CTDirectorJames G. Webb · George Town, Grand Cayman, Cayman IslandsExec · DirectorDavid G. Derosa · George Town, Grand Cayman, Cayman IslandsDirectorHenning G. Bruder · George Town, Grand Cayman, Cayman IslandsDirectorFred Guerard · Del Mar, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗